AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Simultaneous Treatment of Alcohol Use and Psychiatric Disorders

Summary: Researchers at Purdue University have developed a new technology for treating alcohol use disorder. In addition to targeting reduced alcohol intake, it simultaneously treats depression. This new treatment is meant to help patients suffering from both alcohol use and psychiatric disorders. This treatment should exhibit much fewer side effects and improved efficacy when compared to currently available treatments.

Technology Benefits: Simultaneously treats alcohol use and psychiatric disordersExhibits fewer side effects Improved efficacy

Technology Application: Patients suffering from both alcohol use and psychiatric disordersAlcohol treatment centersHospitals

Detailed Technology Description: Richard Van RijnVan Rijn LabPurdue Medicinal Chemistry and Molecular Pharmacology

Countries: United States

Application No.: None

*Abstract: None

*Background: Alcohol use disorder is a chronic relapsing condition that includes alcohol withdrawal syndrome and is frequently comorbid with chronic pain disorders and mood disorders such as depression and anxiety. There are only a few drugs approved to treat alcohol use disorder. Their only goal is to reduce alcohol cravings. They do not treat psychiatric disorders.

*IP Issue Date: None

*IP Type: Provisional

*Stage of Development: Prototype validation and trial production

*Web Links: Purdue Office of Technology CommercializationPurdue Innovation and EntrepreneurshipRichard Van RijnVan Rijn LabPurdue Medicinal Chemistry and Molecular Pharmacology

Country/Region: USA

For more information, please click Here